Albireo and Genpharm Announce Agreement to Commercialize Bylvay™ (odevixibat) in Saudi Arabia and the Gulf Region "" Bylvay is approved in the U.S. and EU as only once–daily drug indicated for patients with PFIC "" "" PFIC is a life–threatening [...] Read more »